Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_assertion type Assertion NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_head.
- NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_assertion description "[Since IL-1 appears to be involved in VEGF secretion in glial tumors through an autocrine/paracrine mechanism, recombinant human IL-1-ra may evolve as a new agent for anti-angiogenic glioma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_provenance.
- NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_assertion evidence source_evidence_literature NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_provenance.
- NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_assertion SIO_000772 10571418 NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_provenance.
- NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_assertion wasDerivedFrom befree-2016 NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_provenance.
- NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_assertion wasGeneratedBy ECO_0000203 NP268252.RAdveuUo0YJyCWIyIuL5QDF0CJl-CVfhEV2eef2DVQA-Y130_provenance.